ATE404691T1 - Pyruvat-kinase als einem neuen zielmolekül - Google Patents
Pyruvat-kinase als einem neuen zielmolekülInfo
- Publication number
- ATE404691T1 ATE404691T1 AT02748716T AT02748716T ATE404691T1 AT E404691 T1 ATE404691 T1 AT E404691T1 AT 02748716 T AT02748716 T AT 02748716T AT 02748716 T AT02748716 T AT 02748716T AT E404691 T1 ATE404691 T1 AT E404691T1
- Authority
- AT
- Austria
- Prior art keywords
- target molecule
- new target
- pyruvate kinase
- pyruvate
- kinase
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01112601 | 2001-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE404691T1 true ATE404691T1 (de) | 2008-08-15 |
Family
ID=8177529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02748716T ATE404691T1 (de) | 2001-05-23 | 2002-05-23 | Pyruvat-kinase als einem neuen zielmolekül |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040152648A1 (de) |
EP (2) | EP1390525B8 (de) |
AT (1) | ATE404691T1 (de) |
AU (1) | AU2002319180B2 (de) |
CA (1) | CA2448165A1 (de) |
DE (1) | DE60228233D1 (de) |
DK (1) | DK1390525T3 (de) |
ES (1) | ES2312595T3 (de) |
PT (1) | PT1390525E (de) |
WO (1) | WO2002095063A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004016646A2 (en) * | 2002-08-12 | 2004-02-26 | Amynon Bio Tech Gmbh | Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) |
JP2006517788A (ja) * | 2002-12-20 | 2006-08-03 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 15986、2188、20743、9148、9151、9791、44252、14184、42461、8204、7970、25552、21657、26492、2411、15088、1905、28899、63380、33935、10480、12686、25501、17694、15701、53062、49908、21612、38949、6216、46863、9235、2201、6985、9883、12238、18057、21617、39228、49928、54476、62113、64316、12264、32362、58198、2887、3205、8557、9600、9693、44867、53058、55556、57658、2208、10252、10302、14218、33877、10317、10485、25964、14815、1363、1397、14827、21708、3801、64698、2179または13249を使用する癌を処置するための方法および組成物 |
DE10356218A1 (de) * | 2003-12-03 | 2005-06-30 | Bayer Cropscience Ag | Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Pyruvatkinasen aus Pilzen |
WO2006055880A2 (en) * | 2004-11-16 | 2006-05-26 | Genzyme Corporation | Diagnostic pkm2 methods and compositions |
US20060166236A1 (en) * | 2004-12-15 | 2006-07-27 | Chong-Sheng Yuan | Allosteric enzyme coupled immunoassay (AECIA) |
US8552050B2 (en) * | 2007-08-16 | 2013-10-08 | Beth Israel Deaconess Medical Center | Activators of pyruvate kinase M2 and methods of treating disease |
EP2344453B1 (de) | 2008-10-09 | 2016-12-28 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Aktivatoren der humanen pyruvatkinase |
WO2010118063A2 (en) | 2009-04-06 | 2010-10-14 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
ES2619557T3 (es) | 2009-05-04 | 2017-06-26 | Agios Pharmaceuticals, Inc. | Activadores de PKM2 para uso en el tratamiento del cáncer |
EP3241554B1 (de) | 2009-06-29 | 2020-01-29 | Agios Pharmaceuticals, Inc. | Chinolin-8-sulfonamidderivate mit antikrebswirkung |
DK2448581T3 (en) | 2009-06-29 | 2017-03-13 | Agios Pharmaceuticals Inc | Therapeutic compositions and methods for their applications |
ES2812537T3 (es) | 2009-10-21 | 2021-03-17 | Agios Pharmaceuticals Inc | Métodos y composiciones para trastornos relacionados con la proliferación celular |
WO2011050210A1 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
US9206426B2 (en) | 2010-03-05 | 2015-12-08 | The Trustees Of Columbia University In The City Of New York | Inhibitory RNAs to RNA binding proteins hnRNPA1, hnRNPA2 and PTB and uses thereof |
US20130109672A1 (en) | 2010-04-29 | 2013-05-02 | The United States Of America,As Represented By The Secretary, Department Of Health And Human Service | Activators of human pyruvate kinase |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
EP2655350B1 (de) | 2010-12-21 | 2016-03-09 | Agios Pharmaceuticals, Inc. | Bicyclische pkm2-aktivatoren |
TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
WO2012151451A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
MA44392B1 (fr) | 2015-06-11 | 2023-10-31 | Agios Pharmaceuticals Inc | Procédés d'utilisation d'activateurs de la pyruvate kinase |
TW202244048A (zh) | 2017-03-20 | 2022-11-16 | 美商佛瑪治療公司 | 作為丙酮酸激酶(pkr)活化劑之吡咯并吡咯組成物 |
BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
US20230055923A1 (en) | 2018-09-19 | 2023-02-23 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821254A (en) * | 1995-02-17 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
AU6333598A (en) * | 1997-02-11 | 1998-08-26 | Regents Of The University Of California, The | Methods of inducing cell cycle stasis |
US7074895B2 (en) * | 1997-08-21 | 2006-07-11 | Quark Biotech, Inc. | Sequences characteristic of hypoxia-regulated gene transcription |
US5948628A (en) * | 1997-09-05 | 1999-09-07 | The Board Of Regents Of The University Of Oklahoma | Methods of screening for compounds which mimic galectin-1 |
US6458538B1 (en) * | 1999-12-14 | 2002-10-01 | Ptc Therapeutics, Inc. | Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay |
-
2002
- 2002-05-23 AU AU2002319180A patent/AU2002319180B2/en not_active Ceased
- 2002-05-23 PT PT02748716T patent/PT1390525E/pt unknown
- 2002-05-23 CA CA002448165A patent/CA2448165A1/en not_active Abandoned
- 2002-05-23 DK DK02748716T patent/DK1390525T3/da active
- 2002-05-23 WO PCT/EP2002/005684 patent/WO2002095063A1/en active IP Right Grant
- 2002-05-23 ES ES02748716T patent/ES2312595T3/es not_active Expired - Lifetime
- 2002-05-23 EP EP02748716A patent/EP1390525B8/de not_active Expired - Lifetime
- 2002-05-23 AT AT02748716T patent/ATE404691T1/de not_active IP Right Cessation
- 2002-05-23 DE DE60228233T patent/DE60228233D1/de not_active Expired - Lifetime
- 2002-05-23 US US10/478,679 patent/US20040152648A1/en not_active Abandoned
- 2002-05-23 EP EP08014232A patent/EP1990422A1/de not_active Withdrawn
-
2007
- 2007-06-29 US US11/771,462 patent/US20080021116A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002095063A1 (en) | 2002-11-28 |
ES2312595T3 (es) | 2009-03-01 |
EP1390525A1 (de) | 2004-02-25 |
DE60228233D1 (de) | 2008-09-25 |
EP1990422A1 (de) | 2008-11-12 |
EP1390525B1 (de) | 2008-08-13 |
AU2002319180B2 (en) | 2007-07-05 |
CA2448165A1 (en) | 2002-11-28 |
DK1390525T3 (da) | 2008-12-08 |
US20080021116A1 (en) | 2008-01-24 |
EP1390525B8 (de) | 2009-03-04 |
US20040152648A1 (en) | 2004-08-05 |
PT1390525E (pt) | 2008-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60228233D1 (de) | Pyruvat-kinase als einem neuen zielmolekül | |
DE60330895D1 (de) | Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen | |
HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
GB0325956D0 (en) | Novel compounds | |
IL176674A (en) | Variables of fc domain | |
SE0202838D0 (sv) | Chemical compounds | |
DE60131967D1 (de) | Nr1h4-kern-rezeptor-bindende verbindungen | |
CY1109104T1 (el) | 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου | |
HK1129103A1 (en) | Prodrugs of gaba analogs, compositions and uses thereof gaba | |
CL2013002895A1 (es) | Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005). | |
ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
BR9701248A (pt) | Novos pró-medicamentos para a terapia de tumores e distúrbios inflamatórios | |
DK1379246T3 (da) | Nocieptin-analoger | |
EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
DE60231107D1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
SE0101082D0 (sv) | Novel use | |
DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
WO2003091243A8 (en) | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics | |
DE60213541D1 (de) | Discodermolid-Analoga und ihre pharmazeutische Verwendung | |
WO2002062297A3 (en) | Methods and compositions for modulating gluconeogenesis using pgc-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1390525 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |